Comparison

PCO371 European Partner

Item no. TMO-T16442-5mg
Manufacturer TargetMol
CASRN 1613373-33-3
Amount 5mg
Category
Type Molecules
Format Powder
Specific against other
Purity 0,98
Smiles CC(C)(C(NC1=O)=O)N1c1cc(C)c(CCS(N(CC2)CCC22N=C(c(cc3)ccc3OC(F)(F)F)NC2=O)(=O)=O)c(C)c1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 1613373-33-3, 2,4-Imidazolidinedione, 1-(3,5-dimethyl-4-(2-((4-oxo-2-(4-(trifluoromethoxy)phenyl)-1,3,8-triazaspiro(4.5)dec-1-en-8-yl)sulfonyl)ethyl)phenyl)-5,5-dimethyl-
Available
Short Description
PCO371 is an orally active full agonist of parathyroid hormone receptor 1. It has no effect on PTH type 2 receptor.
Shipping
cool pack
Storage
-20°
Target names or alias
2, 4-Imidazolidinedione, 1-(3, 5-dimethyl-4-(2-((4-oxo-2-(4-(trifluoromethoxy)phenyl)-1, 3, 8-triazaspiro(4.5)dec-1-en-8-yl)sulfonyl)ethyl)phenyl)-5, 5-dimethyl-
Molecular Weight
635, 65
Pathway
Endocrinology/Hormones
Target
Thyroid hormone receptor(THR)

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?